| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $410.2M | $352.2M | $374.8M |
| YoY Revenue Growth % | +16.5% | -6.0% | — |
| Gross Profit | $246.2M | $190.2M | — |
| Gross Margin % | 60.0% | 54.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $84.2M | $43.9M | $50.4M |
| Operating Margin % | 20.5% | 12.5% | 13.4% |
| Net Income (GAAP) | $34.9M | $26.1M | $25.3M |
| EBITDA (Normalized) | $90.8M | $50.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $127.1M | $70.8M | $58.6M |
| Capital Expenditures (CapEx) | $8.2M | $8.4M | — |
| Free Cash Flow (FCF) | $118.9M | $62.4M | $58.6M |
| FCF Margin % | 29.0% | 17.7% | 15.6% |
| Return on Invested Capital (ROIC %) | 35.6% | 17.4% | — |
| Cash & Short-Term Equivalents | $151.2M | $100.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $337.9M | $299.5M | — |